Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia

Current Opinion in Urology

Volumn 16, Issue 1, 2006, Pages 11-19

  Rosen, Raymond C ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Benign prostatic hyperplasia; Ejaculatory dysfunction; Erectile dysfunction; Lower urinary tract symptoms; Sexual dysfunction

Indexed keywords

ALFUZOSIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOXAZOSIN; DUTASTERIDE; FINASTERIDE; PHOSPHODIESTERASE V INHIBITOR; TAMSULOSIN; TERAZOSIN;

AUSTRALIA; BODY MASS; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; EJACULATION DISORDER; ERECTILE DYSFUNCTION; GERMANY; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; RISK FACTOR; SAUDI ARABIA; SEX ROLE; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; TREATMENT OUTCOME; UNITED STATES; URETHRA; URETHRA DISEASE; URINARY TRACT DISEASE;

EID: 29944437783     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2005.12.114     Document Type: Note

References (36)

1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132:474-479.
2. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151:54-61.
3. Rosen R, Carson C, Giuliano F. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol 2005; 47:824-837. A comprehensive review of the results of large-scale epidemiological studies on the relationship between LUTS and male sexual dysfunction.
4. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999; 281:537-544.
5. Braun M, Wassmer G, Klotz T, et al. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res 2000; 12:305-311.
6. Braun MH, Sommer F, Haupt G, et al. Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical 'Aging Male' symptoms? Results of the 'Cologne Male Survey'. Eur Urol 2003; 44:588-594.
7. Blanker MH, Bosch JL, Groeneveld FP, et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology 2001; 57:763-768.
8. Blanker MH, Bohnen AM, Groeneveld FP, et al. Correlates for erectile and ejaculatory dysfunction in older Dutch men: a community-based study. J Am Geriatr Soc 2001; 49:436-442.
9. Nicolosi A, Glasser DB, Moreira ED, Villa M. Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study. Int J Impot Res 2003; 15:253-257.
10. Rosen R, Altwein J, Boyle P, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44:637-649.
11. Vallancien G, Emberton M, Harving N, van Moorselaar RJ. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol 2003; 169:2257-2261.
12. Hansen BL. Lower urinary tract symptoms (LUTS) and sexual function in both sexes. Eur Urol 2004; 46:229-234. A large, population-based study evaluating the association between LUTS and sexual dysfunction in both men and women.
13. Ponholzer A, Temml C, Obermayr R, Madersbacher S. Association between lower urinary tract symptoms and erectile dysfunction. Urology 2004; 64:772-776. A large, health-screening study evaluating different types of LUTS and their association with erectile dysfunction.
14. Ponholzer A, Temml C, Mock K, et al. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005; 47:80-85 [discussion 85-6]. A large, health-screening study of independent risk factors for erectile dysfunction.
15. Terai A, Ichioka K, Matsui Y, Yoshimura K. Association of lower urinary tract symptoms with erectile dysfunction in Japanese men. Urology 2004; 64:132-136. A large, health-screening study of the association between various health and lifestyle variables and erectile dysfunction.
16. Elliott SP, Gulati M, Pasta DJ, et al. Obstructive lower urinary tract symptoms correlate with erectile dysfunction. Urology 2004; 63:1148-1152.
17. Sak SC, Hussain Z, Johnston C, Eardley I. What is the relationship between male sexual function and lower urinary tract symptoms (LUTS)? Eur Urol 2004; 46:482-487.
18. Shiri R, Hakkinen JT, Hakama M, et al. Effect of lower urinary tract symptoms on the incidence of erectile dysfunction. J Urol 2005; 174:205-209 [discussion 209]. A longitudinal, population-based study of the association between LUTS and the incidence of erectile dysfunction during 5 years of follow-up.
19. Laumann EO, Nicolosi A, Glasser DB, et al. Sexual problems among women and men aged 40-80 y: prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005; 17:39-57. A comprehensive evaluation of the prevalence rates of premature ejaculation, ejaculatory dysfunction, and erectile dysfunction and their risk factors in seven geographical regions. Women's sexual problems and associated risk factors are also evaluated.
20. Chung WS, Nehra A, Jacobson DJ, et al. Lower urinary tract symptoms and sexual dysfunction in community-dwelling men. Mayo Clin Proc 2004; 79:745-749. A cross-sectional study of the effects of age on the association between LUTS and male sexual function.
21. Hoesl CE, Woll EM, Burkart M, Altwein JE. Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS). Eur Urol 2005; 47:511-517. A clinic-based study of the association between LUTS severity and erectile dysfunction prevalence in men with BPH.
22. El-Sakka A. Lower urinary tract symptoms in patients with erectile dysfunction: analysis of risk factors. J. Sex. Med, (In press).
23. Paick SH, Meehan A, Lee M, et al. The relationship among lower urinary tract symptoms, prostate specific antigen and erectile dysfunction in men with benign prostatic hyperplasia: results from the PROscar long-term efficacy and safety study. J Urol 2005; 173:903-907.
24. Rosen R, Althof S, Catania J, O'Leary MP, Seftel A. Lower urinary tract symptoms and sexual dysfunction: epidemiological findings from the Men's Sexual Health Population Survey. J Urol 2005; 173 [Abstract 19]. Preliminary data from the Men's Sexual Health Population Survey on the relationship between LUTS and erectile dysfunction or ejaculatory dysfunction in a representative sample of relatively healthy men.
25. Holden CA, McLachlan RI, Pitts M, et al. Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 2005; 366:218-224. A national study of the prevalence of erectile dysfunction, LUTS, prostate disease, and androgen deficiency and related concerns in aging men.
26. McVary KT. Erectile Dysfunction and Lower Urinary Tract Symptoms Secondary to BPH. Eur Urol 2005; 47:838-845. An excellent review in which the association between LUTS/BPH and erectile dysfunction is examined using Hill's criterion.
27. Rajfer J. Endothelial dysfunction as a cause of erectile dysfunction - misdiagnosis or misnomer? Urology 2004; 64:193-194.
28. Sairam K, Kulinskaya E, McNicholas TA, et al. Sildenafil influences lower urinary tract symptoms. BJU Int 2002; 90:836-839.
29. van Moorselaar RJ, Hartung R, Emberton M, et al. Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction. BJU Int 2005; 95:603-608. A practice-based study of the effect of alfuzosin 10 mg once daily on sexual function in men with LUTS/BPH and concomitant erectile dysfunction and/or ejaculatory dysfunction.
30. Kirby RS, O'Leary MP, Carson C. Efficacy of extended-release doxazosin and doxazosin standard in patients with concomitant benign prostatic hyperplasia and sexual dysfunction. BJU Int 2005; 95:103-109 [discussion 109]. A study of the effects of two formulations of doxazosin on sexual function in men with LUTS/BPH and concomitant erectile dysfunction.
31. Roehrborn CG, Van Kerrebroeck P, Nordling J. Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU Int 2003; 92:257-261.
32. FLOMAX. (tamsulosin hydrochloride) [prescribing information]. Ridgefield, CT: Boehringer lngelheim Pharmaceuticals, Inc. 2002.
33. Hellstrom WJG, Smith W, Sikka SC. Effects of alpha-blockers on ejaculatory function in normal subjects. J Urol 2005; 173 [Abstract 874]. A placebo-controlled, crossover study on the effects of alfuzosin 10 mg once daily and tamsulosin 0.8 mg once daily on ejaculatory function in healthy men.
34. Nickel JC, Fradet Y, Boake RC, et al. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study. CMAJ 1996; 155:1251-1259.
35. Brookes ST, Donovan JL, Peters TJ, et al. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ 2002; 324:1059-1061.
36. Rosen R, Catania J, Pollack L, et al. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. Urology 2004; 64:777-782. A report on the psychometric validation of the self-administered MSHQ, which assesses erection, ejaculation, and satisfaction in aging men.